InsidersTradesSigma
Track the Scancell Holdings plc share price and the full insider trade history of the company, a listed equity based in United Kingdom. Shares are quoted on UK GB, under the authority of RNS (LSE). The latest transaction was filed on 4 August 2025 (Purchase). Among the most active insiders: Vulpes Testudo Fund. Every trade is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Scancell Holdings plc is a UK-based biopharmaceutical company focused on developing immunotherapeutic treatments for cancer. It concentrates on innovative approaches to stimulate patients' immune systems.